Navigation Links
Open Biosystems' Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland
Date:4/7/2008

Unique program continues to advance collaborative research worldwide

HUNTSVILLE, Ala., April 7, 2008 /PRNewswire/ -- Open Biosystems, Inc., announced today that leading research institutions, the Institute for Molecular Bioscience and Diamantina Institute at the University of Queensland, and the Biotech Research and Innovation Centre (BRIC) along with the University of Copenhagen have recently purchased access to Open Biosystems shRNAmir technologies for RNAi by joining the Open Access RNAi(TM) Program.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070423/CLM143LOGO )

Both institutions purchased access to Open Biosystems' lentiviral shRNAmir human and mouse libraries developed in collaboration with Dr. Greg Hannon and Dr. Steve Elledge and exclusively distributed through Open Biosystems.

"Once complete, the Institute for Molecular Bioscience's lentiviral screening facility will be unique in the Southern Hemisphere," Professor John Hancock, Deputy Director (Research) of the IMB, said. "Open Biosystems' Open Access RNAi Program will give all of our research groups access to this valuable genomic screening resource. This will allow our researchers to conduct whole genome or customized gene set knock down experiments that will greatly facilitate discovery in our cell, developmental biology and cancer research programs."

"The lentiviral shRNAmir libraries are important tools for our high throughput genomic facilities," said Professor Kristian Helin, Director of BRIC. "The research groups at University of Copenhagen will now have access to state-of-the art screening facilities to discover novel genes involved in cell-fate decisions and disease."

"We are excited to see worldwide adoption of our Open Access Program. This fuels our ongoing mission to make leading edge technology broadly available in a technically supported and cost-effective way. Lentiviral RNAi screening facilities such as these being developed by our Open Access partners puts genome scale RNAi screening within the reach of all researchers. This will surely accelerate the pace of research and the treatment of human disease," said Troy Moore, Chief Technology Officer at Open Biosystems.

Open Biosystems' portfolio of RNAi resources include shRNAmir lentiviral and retroviral libraries targeting the entire human and mouse genomes, the RNAi Consortium human and mouse lentiviral shRNA libraries as well as RNAi collections targeting Drosophila, C. elegans and Arabidopsis thaliana. Participation in the Open Access RNAi program, provides researchers the most complete and flexible access to their choice of these rapidly evolving RNAi technologies.

About Open Access RNAi

The Open Biosystems Open Access RNAi Program gives entire academic systems, including multiple campuses, access to the company's advanced shRNA libraries, priority technical support, and continued access to all extensions of existing libraries as well as library upgrades. In this manner, Open Biosystems supports academic research without imposing heavy financial burdens on individual labs. The program is customizable and can be tailored to fit the diverse needs of research institutions worldwide. Complete details can be found at http://www.openbiosystems.com/OpenAccessRNAi

About Open Biosystems

Open Biosystems, Inc. develops, manufactures and markets genomic research tools to scientists and researchers in corporate, academic and government laboratories. These research tools provide investigators with standardized high-quality genes, RNAi and antibodies for interrogating gene function in relation to oncology, neuroscience and metabolic disorders. Founded in 2001, Open Biosystems is headquartered in Huntsville, Alabama. For more information and details for ordering, please visit http://www.openbiosystems.com


'/>"/>
SOURCE Open Biosystems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
2. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
3. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
4. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
5. Primera Biosystems Raises $21 Million in Series B Private Round
6. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
7. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
8. Study Finds Broadband Access Key to Empowerment of Minority Communities
9. Singulex Collaborates With Large Pharmaceutical Company in Erenna(TM) Technology Access Program
10. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
11. Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers ... The result of a collaboration among several companies with expertise in toolholding, cutting ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
(Date:6/22/2016)... Research and Markets has announced the addition of the "Biomarkers: ... The global biomarkers market has grown ... market is expected to grow at a five-year compound annual growth ... billion in 2015 to $96.6 billion in 2020. ... 2020) are discussed. As well, new products approved in 2013 and ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
(Date:3/22/2016)... , March 22, 2016 ... report "Electronic Sensors Market for Consumer Industry by Type ... Others), Application (Communication & IT, Entertainment, Home ... Global Forecast to 2022", published by MarketsandMarkets, ... expected to reach USD 26.76 Billion by ...
Breaking Biology News(10 mins):